Research ArticleOncology
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot and Marjolijn N. Lub-de Hooge
Journal of Nuclear Medicine November 2020, 61 (11) 1594-1601; DOI: https://doi.org/10.2967/jnumed.120.241877
Frans V. Suurs
1Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands
Grit Lorenczewski
2Amgen Research Munich GmbH, Munich, Germany; and
Sabine Stienen
2Amgen Research Munich GmbH, Munich, Germany; and
Matthias Friedrich
2Amgen Research Munich GmbH, Munich, Germany; and
Elisabeth G.E. de Vries
1Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands
Derk Jan A. de Groot
1Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands
Marjolijn N. Lub-de Hooge
3Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 11
November 1, 2020
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot, Marjolijn N. Lub-de Hooge
Journal of Nuclear Medicine Nov 2020, 61 (11) 1594-1601; DOI: 10.2967/jnumed.120.241877
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot, Marjolijn N. Lub-de Hooge
Journal of Nuclear Medicine Nov 2020, 61 (11) 1594-1601; DOI: 10.2967/jnumed.120.241877
Jump to section
Related Articles
Cited By...
- No citing articles found.